financetom
Business
financetom
/
Business
/
Taylor Swift's 'Eras' tour movie presales smash all Marvel box office records — scares even 'The Exorcist'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taylor Swift's 'Eras' tour movie presales smash all Marvel box office records — scares even 'The Exorcist'
Sep 4, 2023 9:39 AM

Taylor Swift is back at it again. After smashing records with her Eras tour, the singer is all set to break box office records with her Eras movie. The intensity of Swift mania has even spooked horror flick The Exorcist: Believer to move out of the way. On August 31, Swift announced that her Eras tour is coming to the big screen as a feature film, premiering in AMC theatres only across the US on October 13.

You might remember that Swift's Eras tour completely broke Ticketmaster — additionally, the ticket presales caused a congressional hearing on the matter. Something similar is happening with the movie as well. AMC Entertainment reported that Thursday (August 31) ticket presales for Swift’s film reached $26 million. This is a new record for the century-old company.

Previously, the highest single-day ticket sales record was held by Spider-Man: No Way Home with $16.9 million. According to a report by CNBC, Fandango, which sells tickets for other theatre chains, said the film ranks in the top 10 all-time best first-day presellers, joining the list with Avengers: Endgame, Star Wars: The Force Awakens and Spider-Man: No Way Home.

“Taylor Swift is giving moviegoing fans and the entire industry the ultimate gift by bringing (the) Taylor Swift Eras Tour concert film to the big screen,” Jerramy Hainline, Senior Vice President at Fandango Ticketing told CNBC.

Previously, her stadium concerts, drawing crowds of 70,000 people, set records and significantly boosted the hotel industry during the pandemic's aftermath. Now, it appears she's poised to have a similar impact on the movie theatre business.

There's little doubt that Swift will fill theatres with eager fans, and the number of shows she's willing to host will likely determine the extent of her success. According to a report by Inc. analysts predict that her concert movie could easily achieve a $100-million opening weekend, firmly placing it in the list of blockbuster films. This year, only a select few movies such as Barbie, The Super Mario Bros. Movie, Spider-Man: Across the Spider-Verse, and Guardians of the Galaxy: Vol. 3 have surpassed the expected opening box office earnings of Swift's concert movie.

When it comes to IMAX, CNBC reported that it has already sold out more than 250 screenings and is over-indexing on presales. The company told CNBC that it is pulling in the same percentage of presales that it would for a blockbuster tentpole feature.

The Exorcist shift

The creators of the soon-to-be-released movie, The Exorcist: Believer, made an announcement on X (formerly Twitter) on Thursday. They have decided to release the horror film one week earlier than planned, moving it away from the same release date as Taylor Swift's Eras tour film, which was originally set for nationwide release on October 13.

ALSO READ | ‘Barbie’ sits pretty atop global box office — at $1.38 billion, it's the biggest hit of 2023

Although both films were initially slated for the same release date, renowned horror producer Jason Blum has chosen to adjust the release date to prevent any potential clash with Swift. In a tweet, Blum, 54, playfully referenced one of Swift's popular songs, saying, Look what you made me do. He then revealed the new release date for The Exorcist: Believer as October 6, 2023.

(Edited by : Shoma Bhattacharjee)

First Published:Sept 4, 2023 6:39 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canada's Unifor, GM start contract talks for CAMI assembly plant
Canada's Unifor, GM start contract talks for CAMI assembly plant
Sep 9, 2024
Sept 9 (Reuters) - General Motors ( GM ) and Unifor have begun collective bargaining for workers at the automaker's CAMI Assembly plant in Ontario, the Canadian labour union said on Monday. A strike mandate showed 97% of Unifor Local 88 members are in favour of a strike if an agreement is not reached by 10:59 p.m. on Sept. 17,...
Apple shows off new Watch with bigger screen as it kicks off iPhone 16 AI event
Apple shows off new Watch with bigger screen as it kicks off iPhone 16 AI event
Sep 9, 2024
CUPERTINO, California (Reuters) -Apple unveiled an updated Watch at an event on Monday focused on its AI-enhanced iPhone 16, although Apple's product showcase risks being overshadowed by Chinese rival Huawei's tri-fold phone, unofficially announced earlier in the day. The Chinese company's website showed on Monday that it had garnered more than 3 million pre-orders for its Z-shaped tri-fold phone. This...
Why UTime (WTO) Stock Is Down 26% Today
Why UTime (WTO) Stock Is Down 26% Today
Sep 9, 2024
UTime Ltd ( WTO ) shares are trading lower by 26.1% to $0.04 Monday afternoon after the company announced a 1-for-25 reverse share split. The reverse split will be effective on or around the open of September 11. This move aims to meet Nasdaq’s minimum $1.00 bid price requirement for continued listing. The reverse split will reduce the total number...
ArriVent BioPharma Lung Cancer Treatment Study Shows Positive Interim Results
ArriVent BioPharma Lung Cancer Treatment Study Shows Positive Interim Results
Sep 9, 2024
01:06 PM EDT, 09/09/2024 (MT Newswires) -- ArriVent BioPharma ( AVBP ) said Monday that interim data from phase 1b study of firmonertinib monotherapy in non-small cell lung cancer patients showed positive systemic and central nervous system responses as of June 20. The proof-of-concept global study of firmonertinib was also generally well-tolerated with a profile consistent with previous data, the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved